Published in Medical Devices and Surgical Technology Week, December 4th, 2005
New products and an expansion of the ev3 sales and distribution organization were the important growth drivers. Reported net sales for ev3 include the consolidated net sales of the company's majority-owned subsidiary, Micro Therapeutics, Inc. (MTIX), an endovascular device company...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week